Gline Matthew

EDGAR CIK 0001750094

Roivant Sciences Ltd. - ROIV

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CEO Director
CEO
Direct Buys
1
$49,957
3,315 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
09/18/2025
09/18/2025
Buy
3,315 @ $15.07
 $49,957 17,287,081 (0.02%) Direct